News

04/29/2013 STC Biologics, Inc presents at PEGS in Boston on lessons learn from biosimilar development


04/20/2013  STC Biologics exhibits at BIO in Chicago and meets with pharmaceutical companies around the world to discuss licensing opportunities for STC101, a biosimilar antibody for treatment of cancer. STC also launches its biosolutions group to help partner companies to expedite their development


11/27/2012 STC Biologics presents at World Generic Medicines Congress of Americas 2011 in Washington DC


10/10/2012  STC Biologics, Inc Receives $2.5M SBIR Phase II Contract from the National Cancer Institute to continue Biosimilar Development

05/15/2012 STC Biologics to attend BIO in Boston


03/30/2012 STC Biologics, Inc presents at PEGS on biosimilar pre-conference workshop


03/09/2012 STC Presents at BPQC Summit at University of Lowell


03/05/2012 STC Biologic,Inc. presents at CBI’s 7th Summit on Biosimilars and Follow-On Biologics in Washington D.C

10/05/2011 STC Biologics presents at the at the “Partnership Opportunities in Drug Delivery (PODD)” Conference being held at the Omni Parker Hotel in Boston, MA

08/25/2011 STC Biologics to present at Business of Biosimilars and Biobetters in Boston, September 19-21

08/25/2011 STC Biologics to present at World Generic Medicines Congress of Americas 2011 in Washington DC, November 15-17, 2011

06/28/2011 STC Biologics, Inc. to present at IIR's Fist Annual Business of Biosimilars conference in Boston, Sep 2009

06/27/2011 STC Biologics, Inc. attends BIO in Washington, DC

06/08/2011 STC Biologics, Inc. to Co-Chair IIR's 2nd Annual Business of Biosimilars conference, Sep-20-2010 through Sep-22-2010 in Boston ,MA

05/25/2011 STC Biologics, Inc. to present at the ACI

09/24/2010 STC Biologics, Inc. to present at World Generic Medicines Congress Americas 2010, Nov-16-2010 at the Westin Grand, Washington DC.

07/30/2010 STC Biologics, Inc. is awarded a contract from National Cancer Institute to develop its first monoclonal antibody biosimilar

 

Developing biologics on faster timelines

Services- What’s New

STC Biologics now offers a variety of services to expedite the development of your drug. We can:

  1. 1.Express your protein of interest in mammalian cells

  2. 2.Measure the activity of your compounds in various cancer cell line (ie proliferation, growth in soft agar, angiogenesis)

  3. 3.Profile your compounds in cancer cells line

  4. 4.Develop a new process for biologic production

  5. 5.Analyze your protein for purity and PTMs

  6. 6.Measure ADCC response

biosimilars

biosolutions